[2025/06/17] Geninus Featured in Cell Reports Medicine
[June 17, 2025] “Research by Geninus CEO Published in Cell Reports Medicine“
A study on residual breast cancer after neoadjuvant chemotherapy has been published in Cell Reports Medicine.
Our CEO contributed as a co-author to this important research, which highlights our company’s commitment to cutting-edge cancer analysis and scientific collaboration.
Study Overview
The study performed spatial and genomic profiling of therapy-resistant cancer cells remaining after neoadjuvant chemotherapy (NAC), focusing on:
-
Spatial distribution and identification of resistant clones and micro-niches
-
Interactions with the tumor microenvironment (TME)
-
Genomic alterations related to treatment resistance (e.g., DNA repair gene mutations)
These findings shed light on the mechanisms of recurrence-prone cancer cells and pave the way for future targeted therapies.
Publication Info
Title: Spatial and genomic profiling of residual breast cancer after neoadjuvant chemotherapy
Journal: Cell Reports Medicine (2025)
